tiprankstipranks
Trending News
More News >

Ventripoint Diagnostics Revises Convertible Debenture Plans

Story Highlights
Ventripoint Diagnostics Revises Convertible Debenture Plans

VentriPoint Diagnostics (TSE:VPT) has released an update.

Confident Investing Starts Here:

Ventripoint Diagnostics has announced its plan to issue common shares to satisfy interest payments on its convertible debentures, pending approval from the TSXV. Additionally, the company has revised the terms of its convertible debenture offering, adjusting conversion rates over the term’s duration.

For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App